MTUM vs VHT
iShares MSCI USA Momentum Factor ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.15% for MTUM.
- • VHT pays a higher dividend yield (1.72%).
Side-by-side metrics
| Metric | MTUM | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.69% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $24.18B | $18.51B |
YTD return | 19.63% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.26 | 0.64 |
P/E ratio | 32.20 | 25.44 |
Last price | $293.91 | $271.09 |
Inception | — | — |
Issuer | iShares | Vanguard |
MTUM top holdings
| MU | Micron Technology Inc | 5.56% |
| AVGO | Broadcom Inc | 5.40% |
| NVDA | NVIDIA Corp | 4.64% |
| AMD | Advanced Micro Devices Inc | 4.03% |
| INTC | Intel Corp | 3.83% |
| JNJ | Johnson & Johnson | 3.76% |
| LRCX | Lam Research Corp | 3.61% |
| XOM | Exxon Mobil Corp | 3.43% |
| CAT | Caterpillar Inc | 3.21% |
| GOOGL | Alphabet Inc Class A | 2.94% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About MTUM
MTUM (iShares MSCI USA Momentum Factor ETF) is US large-caps with momentum tilt. Managed by iShares, the fund carries $24.2B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.69%. Its largest holding is Micron Technology Inc (MU), which represents 5.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.